These agents have multiple effects relevant to brain health: improved glycemic control (lowering glucose spikes, avoiding hyperglycemia) weight loss, which reduces many risk factors (vascular disease, hypertension, dyslipidemia) possible reduction of systemic inflammation possible direct neural effects: crossingor affectingthe blood brain barrier
Despite this potential, there is limited consolidation of evidence regarding their psychiatric applications
Comparing whole-body MMNST data (40) and comparing them with our SSP-MMNSTs, we did not find a significant difference in the rate of metastasis (32.7% vs 31.58%, p= 0.9273) nor recurrence (25% vs 36.8%, p= 0.2639)
When considering options for weight loss, its important to understand how semaglutide and topiramate compare to other treatments
Most insurance providers do not cover peptide therapy
Statistics Statistical analyses were performed using SPSS version 23 (SPSS Inc., Chicago, IL, USA), SAS version 14 (SAS Institute, Cary, North Carolina, USA), and Stata version 12 (Stata Corporation, College Station, TX, USA)
